Bio-Rad Laboratories, Inc.

BIO Healthcare Medical Devices

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue
+0.52%
EPS
+234.9%
Free cash flow
+8.07%
Total debt
+0.11%

Quarter to September 2026, against a year earlier

381.91 12.91 +3.50%
Market cap
$9.9B
P/E
9.7×
Fwd P/E
44.7×
Dividend yield
—
F-score
5/9
Altman Z
3.20
Beneish M
−2.29
Dividend safety
n/a

Bio-Rad Laboratories, Inc. (BIO) Book value per share

Alert me on Book value per share

Bio-Rad Laboratories, Inc.'s book value per share at the end of fiscal 2025 was 273×, up 17.4% from 233× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 284×. Over the past ten years it has ranged from 85.3× (fiscal 2015) to 459× (fiscal 2021); the current reading is higher than 64% of that period. Bio-Rad Laboratories, Inc. ranks 1st of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 273× 17.42%
FY2024 233× (22.20%)
FY2023 299× (7.30%)
FY2022 323× (29.63%)
FY2021 459× 38.22%
FY2020 332× 72.11%
FY2019 193× 43.12%
FY2018 135× 36.37%
FY2017 98.8× 12.79%
FY2016 87.6× 2.67%

Quarterly newest first

Period Book value per share Change
Sep 2026 284× 5.85%
Jun 2026 268× 5.54%
Mar 2026 254× (7.04%)
Dec 2025 273× 9.26%
43 more quarters

Against its own ten years

Low 85.3× High 459×
Ten-year median 233×
Current reading's percentile 64

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on BIO